Abstract
Probiotics and other bacteriotherapies are actively being explored and applied as symptom- and disease-modifying agents. In a recent issue of Cell, two papers contribute to our understanding of how live bacterial therapies variably affect individuals and the short- and longer-term impact of these therapies on colonization and host response.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use
-
Bacteria / growth & development
-
Bacterial Physiological Phenomena*
-
Dysbiosis / microbiology
-
Dysbiosis / therapy
-
Gastrointestinal Diseases / therapy
-
Gastrointestinal Microbiome / drug effects
-
Host Microbial Interactions / physiology
-
Humans
-
Probiotics / therapeutic use*